Made Scientific Unveils $12M Manufacturing Hub in NJ!

BIOT

featured image of Made Scientific Unveils $12M Manufacturing Hub in NJ!
🌟 Made Scientific has opened a new 60,000 sq. ft. GMP manufacturing facility in Princeton, NJ.

💰 This $12 million investment enhances their cell therapy capabilities.

👷‍♂️ An additional 100 skilled jobs are expected as part of their upcoming expansion.

🏗️ The facility includes advanced tech for efficient manufacturing and supports global therapeutic innovations.

📢 Made Scientific Unveils $12M Manufacturing Hub in NJ!

Introduction:

Made Scientific, a Contract Development and Manufacturing Organization (CDMO), has launched its new GMP (Good Manufacturing Practice) manufacturing facility and headquarters in Princeton, New Jersey. This establishment is a significant advancement in the realm of cell therapy manufacturing, reflecting the company’s growth and commitment to supporting innovative therapies.

Main points:

  1. The new facility spans 60,000 square feet and represents a $12 million investment in state-of-the-art equipment and infrastructure.
  2. Made Scientific aims to enhance its manufacturing capacity to support the next generation of cell therapies globally, with a commitment to clinical and commercial manufacturing under one roof.
  3. The facility features five ISO 7/Grade B cleanrooms, quality control labs, and advanced digital systems for seamless operational efficiency.
  4. An additional 12,000 square feet of GMP cleanroom space is planned, aimed at meeting FDA and EU Annex 1 compliance standards and increasing production capabilities.
  5. Made Scientific is expected to expand its workforce by more than 100 skilled professionals to meet the rising demand for cell therapy solutions.

Conclusion:

The grand opening of Made Scientific’s new facility signifies a major step forward in the field of cell therapy manufacturing. With advanced infrastructure and a commitment to compliance and operational excellence, the company is positioned to be a key player in the future of transformative therapies. This expansion not only supports present manufacturing needs but also anticipates future growth in the sector, emphasizing the importance of advanced manufacturing capabilities in responding to global healthcare demands.

Leave a Comment